.png)
.png)
BIA Webinar - China SIG 2024 outlook: current biopharma market conditions and opportunities
Watch the recording of the China SIG 2024 outlook: current biopharma market conditions and opportunities.
Join us for this special update webinar, hosted by BIA and chaired by DBT China, to:
- get the latest on the current biopharma market conditions in China from DBT and CBBC;
- hear from AstraZeneca and CBBC about opportunities for collaboration and partnering in China;
- get your questions answered on doing business with China and what DBT China can help.
Speakers:
Rahul Agarwal
Rahul is Counsellor for Healthcare & Life Sciences for UK’s Department for Business & Trade (DBT) at British Embassy Beijing. He leads on UK trade & investment in emerging opportunities between the UK and China. Previously, from 2017-2023, he worked for six years in DBT London HQ and has led on multiple programmes and opportunities in promoting business with UK and other countries. Key programmes he has led on include the genomics, healthy ageing, one health, health systems strengthening, development and formulating the UK Government’s global health framework. Before DBT, he worked in consulting for EY and is a fellow of the Royal Society of Arts. He has a master in global politics from the London School of Economics (LSE).
Steve Bates
What does your role at BIA involve?
Steve Bates FMed Sci OBE has been leading the UK Bioindustry Association as CEO since 2012. He currently chairs the International Council of Biotech Associations and has been a board member of EuropaBio since 2015. He sits on the UK’s Life Sciences Council. Steve is the visible face of the vibrant UK life sciences industry to government and media. Steve was a founder member of the UK Government’s Vaccine Taskforce in the Covid crisis, sitting on its steering Board alongside Kate Bingham.
Previous experience & achievements
Steve has championed, with government, effective industrial incentives like the Biomedical Catalyst, which have crowded in private sector investment into UK SMEs. He has forged several links for the sector across the USA, Europe and in China. In his time at the BIA, Steve has developed new member groups focused on cell and gene therapy, genomics and engineered biology. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. Proud to lead an organisation with a diverse Board with over 40% female representation, Steve is committed to next-generation talent and developing the skills needed for the sector to flourish. Before the BIA, Steve worked for Genzyme and was an advisor to the UK Government of Tony Blair. He was made OBE for services to innovation in 2017 and became a Fellow of the Academy of Medical Science in 2020.
Chandler Chen
Chandler leads the incubation and partnership platform with regional network across cities nationwide (Beijing, Shanghai, Guangzhou, Hangzhou, Chengdu, Wuxi and Yixing, Qingdao). He is driving the development and enrichment of open innovation & partnering platform for therapeutic area focused ecosystem jointly with cross sectional partners including government, medical institution, industry, academia, research and capital, to co-create holistic patient centric solutions.
Elinor Greenhouse
As sector lead for Tech and Innovation, Elinor is responsible for supporting British tech and healthcare companies entering and operating within the Chinese market, and leads on CBBC’s engagement for intellectual property matters and export licensing regulation. Prior to joining CBBC, Elinor lived in China for eight years, where she worked as an intellectual property strategist advising international companies on IP strategy in China. Elinor is a fluent Mandarin speaker and has previously translated for academic journals in the fields of Economics and Law. She holds a bachelor’s in law from The University of Sheffield and a master’s in Chinese law from Peking University, where she focused her research on the use of AI within China’s smart courts.